We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Chimeracom Receives Patent for Method of Transporting Pharmacologically Active Peptides Across Blood Brain Barrier
News

Chimeracom Receives Patent for Method of Transporting Pharmacologically Active Peptides Across Blood Brain Barrier

Chimeracom Receives Patent for Method of Transporting Pharmacologically Active Peptides Across Blood Brain Barrier
News

Chimeracom Receives Patent for Method of Transporting Pharmacologically Active Peptides Across Blood Brain Barrier

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Chimeracom Receives Patent for Method of Transporting Pharmacologically Active Peptides Across Blood Brain Barrier"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Chimeracom L.L.C. has announced that the US Patent and Trademark Office issued a US patent for the invention by Chimeracom’s Chief Science Officer, Dr. Richard M. Kream, of a novel method for managing a critical problem in the design of pharmaceuticals.

As Dr. Kream explained, “the blood-brain barrier protects the brain from chemicals in the blood. This barrier must be overcome to deliver potentially important therapeutic and diagnostic agents to the brain. Our patent covers a family of new drugs for the delivery of pharmacologically active peptides into the brain.”

This patent emerged from Chimeracom’s research and development of analgesic drugs. The new US Patent is no. 7,214,657, entitled Method of Transporting a Chimeric Hybrid Molecule Across the Blood Brain Barrier.

Advertisement